» Articles » PMID: 28342987

Circular RNAs and Cancer

Overview
Journal Cancer Lett
Specialty Oncology
Date 2017 Mar 27
PMID 28342987
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs (circRNAs) are a type of non-coding RNA molecules that lack a 5'-terminal cap and 3'-terminal poly A tail. A large number of circRNAs have been identified through biological experiments, computational methods and high-throughput sequencing. CircRNA sequence composition determines if a given circRNA is exonic, intronic or retained-intronic. CircRNAs are more abundant and stable than linear mRNAs, and their expression is both step- and location-specific. CircRNAs mediate transcriptional and post-transcriptional regulation of gene and protein expression. CircRNAs regulate cancer development via multiple mechanisms, including miRNA sponges, modulating Wnt signaling pathway and epithelial-mesenchymal transition. An in-depth study of circRNA will provide a better understanding of carcinogenesis and assist in developing clinical diagnostic and therapeutic strategies.

Citing Articles

The crosstalk between non-coding RNAs and oxidative stress in cancer progression.

Sun Q, Lei X, Yang X Genes Dis. 2025; 12(3):101286.

PMID: 40028033 PMC: 11870203. DOI: 10.1016/j.gendis.2024.101286.


Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases.

Song W, Chen X, Wu H, Rahimian N Eur J Med Res. 2024; 29(1):643.

PMID: 39741306 PMC: 11689626. DOI: 10.1186/s40001-024-02230-7.


Whole-Transcriptome Analysis Reveals Potential CeRNA Regulatory Mechanism in against Infection.

Xia Y, Yu X, Yuan Z, Yang Y, Liu Y Biology (Basel). 2024; 13(10).

PMID: 39452097 PMC: 11504436. DOI: 10.3390/biology13100788.


Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1.

Zang X, He X, Xiao C, Lin Q, Wang M, Liu C Mol Cancer. 2024; 23(1):207.

PMID: 39334380 PMC: 11438063. DOI: 10.1186/s12943-024-02124-6.


CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

Gong J, Han G, Chen Z, Zhang Y, Xu B, Xu C J Transl Med. 2024; 22(1):517.

PMID: 38816735 PMC: 11137954. DOI: 10.1186/s12967-024-05233-4.